SINO BIOPHARMACEUTICAL Aktie

 >SINO BIO Aktienkurs 
0.77 EUR    +2.7%    (Tradegate)
Ask: 0.77 EUR / 6461 Stück
Bid: 0.74 EUR / 6810 Stück
Tagesumsatz: 4500 Stück
Realtime Kurs von 8 bis 22 Uhr!
>SINO BIO Performance
1 Woche: -4,9%
1 Monat: -6,1%
3 Monate: -12,5%
6 Monate: -56,3%
1 Jahr: -38,4%
laufendes Jahr: 0%
>SINO BIOPHARMACEUTICAL Aktie
Name:  SINO BIOPHARMACEUTICAL
Land:  China
Sektor:  Gesundheit
ISIN/ Wkn:  KYG8167W1380 / A0CBDJ
Symbol/ Ticker:  SMZ1 (Frankfurt)
Kürzel:  FRA:SMZ1, SMZ1.F, SMZ1:GR
Index:  -
Webseite:  http://www.sino-biopharm...
Marktkapitalisierung:  14720 Mio. EUR
Umsatz:  -
EBITDA:  -
Gewinn je Aktie:  -
Schulden:  -
Liquide Mittel:  -
Umsatz-/ Gewinnwachstum:  -19.40% / -21.40%
KGV/ KGV lG:  47.96 / 48.31
KUV/ KBV/ PEG:  4.88 / 3.78 / 12.37
Gewinnm./ Eigenkapitalr.:  9.99% / 10.06%
Dividende je Aktie:  0.006 EUR
Dividendenrendite/ -schätzung:  0.9% / 1.13%
Div. Historie:  11.12.20 - 0.00213€
14.09.20 - 0.00218€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  SINO BIOPHARMACEUTICAL, SINO BIOPHARMA, SINO BIOPHARM, SINO BIO
Letzte Datenerhebung:  17.01.21
>SINO BIO Eigentümer
Aktien: 18860 Mio. St.
f.h. Aktien: 9840 Mio. St.
Insider Eigner: 47.49%
Instit. Eigner: 15.90%
Leerverk. Aktien: -
>SINO BIO Peer Group

 
06.01.21 - 12:12
Genetron Health, Sino Biopharm′s subsidiary inks strategic partnership for HCCscreen in China (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
17.12.20 - 09:15
Full-day Takeaway: HSI Closes at 26,678, Up 218 pts; HSTI Closes at 8,332, Up 186 pts; SINO BIOPHARM Up over 7%; WUXI BIO-NEW, GCL-POLY ENERGY, MMG, CMOC, KINGDEE INT'L Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 218 pts or 0.8% to 26,678. HSTI rose 186 pts or 2.3% to 8,332. HSCEI gained 83 pts or 0.8% to 10,545. Market turnover reached $128.96 billion.Active Heavyweights:BABA (09988.HK) closed at $258, up 2.8%MEITUAN (03690.HK) closed at $...
17.12.20 - 06:12
Midday Wrap-up: HSI Adds 21 Pts; Drugs Thrive, Bud APAC Slips 5% (AAStocks)
 
At midday, the HSI gained 21 pts or 0.1% to 26,481. HSCEI climbed 28 pts or 0.3% to 10,490. HSTI ascended 75 pts or 0.9% to 8,221. Market turnover whopped $65.607 billion. Drugmakers were in shape. SINO BIOPHARM (01177.HK), INNOVENT BIO (01801.HK) an...
17.12.20 - 05:06
Midday Takeaway: HSI Closes Midday at 26,481, Up 21 pts; HSTI Closes Midday at 8,221, Up 75 pts; SINO BIOPHARM Up over 5%; WUXI BIO-NEW, CMOC, ZAI LAB Hit New Highs (AAStocks)
 
At midday close, HSI rose 21 pts or 0.1% to 26,481. HSTI rose 75 pts or 0.9% to 8,221. HSCEI gained 28 pts or 0.3% to 10,490.Active Heavyweights:BABA (09988.HK) closed at $256.2, up 2.1%AIA (01299.HK) closed at $89.6, down 1.5%MEITUAN (03690.HK) clos...
15.12.20 - 09:15
Full-day Takeaway: HSI Closes at 26,207, Down 182 pts; HSTI Closes at 8,094, Down 34 pts; SINO BIOPHARM Up over 5%; ALI HEALTH, XIAOMI, GCL-POLY ENERGY, GAPACK, LI NING Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI dropped 182 pts or 0.7% to 26,207. HSTI dropped 34 pts or 0.4% to 8,094. HSCEI fell 43 pts or 0.4% to 10,399. Market turnover reached $144.01 billion.Active Heavyweights:MEITUAN (03690.HK) closed at $274.2, down 3%BABA (09988.HK) closed...
12.12.20 - 16:30
Sino Biopharmaceutical: Investing In China′s COVID-19 Vaccine While Sinovac Remains Halted (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
11.12.20 - 11:37
3 positive Impfstoff-News von der Biontech-Aktie, Curevac-Aktie und Sino Biopharmaceutical-Aktie (Fool DE)
 
Curevac plant bereits eine Impfstoff-Zulassung. The post 3 positive Impfstoff-News von der Biontech-Aktie, Curevac-Aktie und Sino Biopharmaceutical-Aktie appeared first on The Motley Fool Deutschland....
11.12.20 - 11:03
SINO BIOPHARM (01177.HK) Vice Chair Buys 15M Co. Shrs Further (AAStocks)
 
SINO BIOPHARM (01177.HK) announced that Senior Vice Chairman Tse Ping had today acquired 15 million shares of the company, involving roughly $100 million.~AAStocks Financial NewsWeb Site: www.aastocks.com...
10.12.20 - 06:03
XFRA : INSTRUMENT_EVENT EQUBF_01 (XETRA)
 
DIVIDEND/INTEREST INFORMATION - 11.12.2020:Das Instrument SMZ1 KYG8167W1380 SINO BIOPH.SUBDIV.HD-,025 EQUITY wird cum Dividende/Zinsen gehandelt am 10.12.2020 und ex Dividende/Zinsen am 11.12.2020 The instrument SMZ1 KYG8167W1380 SINO BIOPH.SUBDIV....
07.12.20 - 10:06
HK Wrap-up: HSI Slips 329 Pts; Banks Subdued, Sino Biopharm Hikes Over 4% (AAStocks)
 
HSI tumbled 329 pts or 1.2% to close at 26,506. HSCEI sagged 151 pts or 1.4% to 10,473. HSTI descended 8 pts or 0.1% to 7,944. Market turnover whopped $135.274 billion.Chinese lenders weakened. CCB (00939.HK), ICBC (01398.HK) and BANKCOMM (03328.HK) ...
07.12.20 - 09:18
Full-day Takeaway: HSI Down 329 pts; HSTI Down 8 pts; SINO BIOPHARM Up over 4%; GCL-POLY ENERGY, MING YUAN CLOUD, LIFETECH SCI Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI dropped 329 pts or 1.2% to 26,506. HSTI dropped 8 pts or 0.1% to 7,944. HSCEI fell 151 pts or 1.4% to 10,473. Market turnover reached $135.27 billion.Active Heavyweights:BABA (09988.HK) closed at $258, down 2.3%MEITUAN (03690.HK) closed...
07.12.20 - 08:30
Sino Biopharm secures room for future growth with US$515 million investment in Sinovac’s Covid-19 vaccine unit (SCMP)
 
Sino Biopharmaceutical on Monday announced a US$515 million investment in Covid-19 vaccine developer Sinovac Life Sciences, as the Beijing-based generic drug maker seeks to expand its reach into vaccine development and sales.The Hong Kong-listed comp...
07.12.20 - 08:24
Sinovac receives up to $500m for Covid-19 vaccine development (PBR)
 
Via its affiliates, the investor Sino Biopharmaceutical has invested around $500m in exchange for about 15% of the total equity interest of Sinovac LS. Earlier to the announcement The post Sinovac receives up to $500m for Covid-19 vaccine developmen...
03.12.20 - 03:03
*Citi Cuts SINO BIOPHARM (01177.HK) TP to $11.6; Rated Buy (AAStocks)
 
~AAStocks Financial NewsWeb Site: www.aastocks.com...
02.12.20 - 04:21
Research Report: Nomura Axes SINO BIOPHARM (01177.HK) TP to $8.97; Rated Buy (AAStocks)
 
Nomura mentioned in its research report that SINO BIOPHARM (01177.HK) had delivered 3Q20 results miss, when revenue slipped 19% yearly. The broker attributed the meager results to pandemic impact, implementation of GPO on old blockbuster products and...
02.12.20 - 03:24
*Nomura Axes SINO BIOPHARM (01177.HK) TP to $8.97; Rated Buy (AAStocks)
 
~AAStocks Financial NewsWeb Site: www.aastocks.com...
01.12.20 - 11:27
HKD918.5M Southbound Trading Net Inflow to TENCENT (AAStocks)
 
There was HKD918.5 million and HKD74.1 million Southbound Trading net inflow to TENCENT (00700.HK) and XIAOMI-W (01810.HK).There was HKD170.6 million and HKD41.9 million Southbound Trading net outflow from SINO BIOPHARM (01177.HK) and MEITUAN-W (0369...
01.12.20 - 09:45
Brokers' Post-Results TPs, Views on SINO BIOPHARM (01177.HK) (AAStocks)
 
Brokers│Ratings│TPs (HK$)Citigroup│Buy│12.8Daiwa│ Buy │11CICC│Outperform│12->10Morgan Stanley│Overweight│9.87BofA Securities│ Overweight │10.09->9.79Credit Suisse│ Ou...
01.12.20 - 07:54
Research Report: C Suisse Axes SINO BIOPHARM (01177.HK) TP to $9.4; Rated Outperform (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
01.12.20 - 06:06
Midday Wrap-up: HSI Spurts 244 Pts, Led by CN Banks; SINO BIOPHARM Dives Over 10% (AAStocks)
 
At midday, the HSI leaped 244 pts or 0.9% to 26,586. HSCEI jumped 125 pts or 1.2% to 10,671. HSTI sagged 12 pts or 0.2% to 8,007. Market turnover aggregated $87.47 billion. Chinese financials were the key contributors to the market. Chinese banks CCB...
>Zitat des Tages: Die Österreicher sind überhaupt arme Hund! Die verdienen nix; nicht einmal ein Zehntel dessen, was sie in Deutschland bekommen würden. - Harti Weirather
Partner:    >Tradegate Börse | >TraderFox Handelssignale | >Heibel-Ticker Börsenbrief | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf Twitter | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!